| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $300K | $0 | $0 | — | — |
| Cost of revenue | $300K | $0 | $0 | — | — |
| Research and development | $493.9M+38.1% | $357.7M+29.4% | $276.4M+61.2% | $171.5M+166.7% | $64.3M |
| General and administrative | $235.4M+54.9% | $152.0M-9.7% | $168.4M+2.0% | $165.1M-6.6% | $176.7M |
| Other warrant expense | $0 | $0-100.0% | $2.1M-80.6% | $10.8M-90.8% | $117.3M |
| Total operating expenses | $729.6M+43.1% | $509.7M+14.1% | $446.9M+28.6% | $347.4M-3.0% | $358.3M |
| Loss from operations | -$729.3M-43.1% | -$509.7M-14.1% | -$446.9M-28.6% | -$347.4M+3.0% | -$358.3M |
| Other income (expense), net | $58.6M+220.1% | -$48.8M-81.4% | -$26.9M-196.8% | $27.8M+162.3% | $10.6M |
| Interest income, net | $52.8M+141.1% | $21.9M+33.5% | $16.4M+613.0% | $2.3M+330.0% | -$1.0M |
| Loss before income taxes | -$617.9M-15.2% | -$536.6M-17.3% | -$457.4M-44.2% | -$317.3M+8.8% | -$347.8M |
| Income tax expense | -$300K-50.0% | -$200K+60.0% | -$500K | $0 | $0 |
| Net loss | -$618.2M-15.2% | -$536.8M-17.2% | -$457.9M-44.3% | -$317.3M+8.8% | -$347.8M |
| Net loss per share, basic (in dollars per share) | -$990.00+30.3% | -$1420.00+16.0% | -$1690.00+99.9% | -$1320000.00-41938.2% | -$3140.00 |
| Net loss per share, diluted (in dollars per share) | -$990.00+30.3% | -$1420.00+16.0% | -$1690.00+99.9% | -$1320000.00-41938.2% | -$3140.00 |
| Weighted-average common shares, basic (in shares) | 624.31B+65.7% | 376.73B+39.3% | 270.41B-99.9% | 240.48T+216865.9% | 110.84B |
| Weighted-average common shares, diluted (in shares) | 624.31B+65.7% | 376.73B+39.3% | 270.41B+12.4% | 240.48B+117.0% | 110.84B |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.